See more : Advagene Biopharma Co., Ltd. (6709.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Mesa Laboratories, Inc. (MLAB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mesa Laboratories, Inc., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- Bitmine Immersion Technologies, Inc. (BMNR) Income Statement Analysis – Financial Results
- News Corporation (0K7U.L) Income Statement Analysis – Financial Results
- Streamify AB (STREAM.ST) Income Statement Analysis – Financial Results
- RaySearch Laboratories AB (publ) (RSLBF) Income Statement Analysis – Financial Results
- Dong-A ST Co., Ltd. (170900.KS) Income Statement Analysis – Financial Results
Mesa Laboratories, Inc. (MLAB)
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.19M | 219.08M | 184.34M | 133.94M | 117.69M | 103.14M | 96.18M | 93.67M | 84.66M | 71.33M | 52.72M | 46.44M | 39.62M | 32.83M | 21.93M | 21.54M | 19.56M | 17.24M | 11.58M | 10.04M | 9.13M | 9.08M | 9.04M | 9.10M | 8.66M | 8.10M | 7.90M | 7.80M | 8.10M | 6.60M | 6.20M | 4.40M | 3.80M | 3.50M | 2.80M | 1.10M | 1.00M |
| Cost of Revenue | 82.94M | 85.39M | 75.25M | 46.92M | 52.75M | 42.22M | 41.56M | 40.43M | 33.25M | 27.94M | 21.04M | 17.57M | 16.11M | 13.26M | 8.74M | 7.72M | 6.70M | 6.35M | 4.15M | 3.72M | 3.43M | 3.40M | 3.65M | 3.07M | 2.80M | 2.40M | 2.50M | 2.70M | 2.80M | 2.20M | 2.10M | 1.40M | 1.20M | 1.20M | 1.20M | 400.00K | 400.00K |
| Gross Profit | 133.25M | 133.69M | 109.09M | 87.01M | 64.93M | 60.92M | 54.62M | 53.24M | 51.41M | 43.39M | 31.69M | 28.86M | 23.51M | 19.57M | 13.19M | 13.82M | 12.86M | 10.90M | 7.44M | 6.32M | 5.70M | 5.68M | 5.39M | 6.03M | 5.85M | 5.70M | 5.40M | 5.10M | 5.30M | 4.40M | 4.10M | 3.00M | 2.60M | 2.30M | 1.60M | 700.00K | 600.00K |
| Gross Profit Ratio | 61.64% | 61.02% | 59.18% | 64.97% | 55.17% | 59.06% | 56.79% | 56.84% | 60.73% | 60.83% | 60.10% | 62.16% | 59.35% | 59.61% | 60.17% | 64.16% | 65.74% | 63.19% | 64.21% | 62.94% | 62.44% | 62.59% | 59.61% | 66.30% | 67.62% | 70.37% | 68.35% | 65.38% | 65.43% | 66.67% | 66.13% | 68.18% | 68.42% | 65.71% | 57.14% | 63.64% | 60.00% |
| Research & Development | 19.30M | 20.49M | 15.77M | 10.39M | 6.36M | 3.51M | 3.54M | 4.16M | 3.97M | 3.29M | 2.32M | 2.01M | 1.36M | 1.44M | 669.00K | 636.00K | 532.00K | 392.00K | 358.00K | 358.00K | 332.00K | 259.97K | 289.94K | 308.17K | 281.65K | 200.00K | 300.00K | 300.00K | 300.00K | 400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 72.87M | 72.44M | 60.31M | 45.70M | 37.83M | 31.30M | 26.26M | 22.81M | 23.62M | 17.06M | 11.46M | 9.12M | 5.42M | 4.58M | 2.54M | 2.52M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 38.63M | 37.44M | 28.31M | 18.48M | 12.91M | 8.26M | 8.82M | 9.96M | 7.50M | 7.18M | 6.12M | 4.63M | 3.91M | 3.69M | 2.62M | 3.05M | 2.85B | 2.77B | 1.88B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 111.49M | 109.88M | 88.62M | 64.18M | 50.74M | 39.56M | 35.08M | 32.77M | 31.12M | 24.23M | 17.58M | 13.75M | 9.33M | 8.26M | 5.16M | 5.57M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 1.80M | 2.30M | 1.60M | 1.30M | 1.20M | 1.00M | 600.00K | 600.00K |
| Other Expenses | 274.53M | -3.71M | -1.13M | 91.00K | 50.00K | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | 350.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| Operating Expenses | 406.55M | 130.37M | 104.39M | 74.66M | 57.14M | 43.06M | 38.62M | 36.93M | 35.09M | 27.53M | 19.90M | 15.76M | 10.68M | 9.70M | 5.83M | 6.21M | 5.80M | 5.24M | 3.33M | 2.85M | 2.45M | 2.50M | 2.45M | 2.71M | 3.01M | 2.60M | 2.60M | 2.60M | 2.90M | 2.50M | 2.50M | 1.70M | 1.40M | 1.40M | 1.10M | 600.00K | 600.00K |
| Cost & Expenses | 488.26M | 215.76M | 179.63M | 121.58M | 109.90M | 85.28M | 80.18M | 77.35M | 68.34M | 55.47M | 40.94M | 33.33M | 26.79M | 22.96M | 14.56M | 13.93M | 12.50M | 11.58M | 7.47M | 6.57M | 5.88M | 5.90M | 6.10M | 5.77M | 5.81M | 5.00M | 5.10M | 5.30M | 5.70M | 4.70M | 4.60M | 3.10M | 2.60M | 2.60M | 2.30M | 1.00M | 1.00M |
| Interest Income | 0.00 | 4.77M | 3.89M | 107.00K | 960.00K | 1.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 86.00K | 195.00M | 130.00M | 193.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.70M | 3.71M | 3.89M | 8.02M | 5.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 31.57M | 33.13M | 25.07M | 17.47M | 12.87M | 9.47M | 9.47M | 8.74M | 7.17M | 5.66M | 3.84M | 3.43M | 2.22M | 1.84M | 786.00K | 788.00K | 742.00K | 669.00K | 93.00K | 90.00K | 97.00K | 115.35K | 115.09K | 521.69K | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| EBITDA | -238.38M | 36.45M | 29.77M | 12.36M | 8.09M | 18.09M | 9.77M | 25.05M | 23.50M | 21.52M | 15.63M | 16.54M | 14.55M | 11.71M | 8.15M | 8.40M | 7.80M | 6.33M | 4.20M | 3.57M | 3.35M | 3.30M | 3.06M | 3.85M | 3.18M | 3.30M | 3.20M | 2.70M | 2.70M | 2.20M | 1.80M | 1.40M | 1.30M | 1.10M | 600.00K | 100.00K | 0.00 |
| EBITDA Ratio | -110.26% | 1.52% | 2.55% | 9.23% | 6.87% | 34.28% | 31.01% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 39.22% | 36.01% | 33.76% | 38.99% | 39.90% | 36.70% | 36.29% | 35.50% | 36.66% | 36.36% | 33.80% | 43.13% | 36.72% | 37.04% | 35.44% | 33.33% | 32.10% | 33.33% | 29.03% | 29.55% | 31.58% | 31.43% | 21.43% | 9.09% | 0.00% |
| Operating Income | -272.08M | -30.50M | -20.37M | -5.30M | -4.90M | 9.78M | 2.18M | 16.31M | 16.32M | 15.86M | 11.79M | 13.10M | 12.48M | 9.86M | 7.37M | 7.61M | 7.06M | 5.66M | 4.11M | 3.48M | 3.25M | 3.19M | 2.94M | 2.81M | 2.85M | 3.10M | 2.80M | 2.50M | 2.40M | 1.90M | 1.60M | 1.30M | 1.20M | 900.00K | 500.00K | 100.00K | 0.00 |
| Operating Income Ratio | -125.85% | -13.92% | -11.05% | -3.96% | -4.16% | 9.48% | 2.27% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 31.49% | 30.05% | 33.60% | 35.33% | 36.10% | 32.82% | 35.48% | 34.61% | 35.60% | 35.09% | 32.53% | 30.84% | 32.87% | 38.27% | 35.44% | 32.05% | 29.63% | 28.79% | 25.81% | 29.55% | 31.58% | 25.71% | 17.86% | 9.09% | 0.00% |
| Total Other Income/Expenses | -3.57M | -3.71M | -1.13M | -10.06M | -4.06M | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | -146.00K | -113.00K | 36.00K | 86.00K | 195.00K | 130.00K | 193.00K | 98.00K | 50.00K | 55.16K | 78.51K | 70.96K | 243.83K | 100.00K | 400.00K | 100.00K | 0.00 | -100.00K | -100.00K | 0.00 | 100.00K | 100.00K | 0.00 | 100.00K | 0.00 |
| Income Before Tax | -275.65M | -389.00K | 3.57M | 2.30M | 3.43M | 8.62M | 301.00K | 14.30M | 15.56M | 15.35M | 13.10M | 12.98M | 12.33M | 9.75M | 7.40M | 7.69M | 7.26M | 5.79M | 4.30M | 3.57M | 3.30M | 3.24M | 3.02M | 2.88M | 3.09M | 3.20M | 3.20M | 2.60M | 2.40M | 1.80M | 1.50M | 1.30M | 1.30M | 1.00M | 0.00 | 200.00K | 0.00 |
| Income Before Tax Ratio | -127.50% | -0.18% | 1.94% | 1.72% | 2.92% | 8.36% | 0.31% | 15.26% | 18.37% | 21.52% | 24.85% | 27.95% | 31.13% | 29.71% | 33.76% | 35.73% | 37.10% | 33.57% | 37.15% | 35.58% | 36.15% | 35.69% | 33.40% | 31.62% | 35.69% | 39.51% | 40.51% | 33.33% | 29.63% | 27.27% | 24.19% | 29.55% | 34.21% | 28.57% | 0.00% | 18.18% | 0.00% |
| Income Tax Expense | -21.40M | -1.32M | 1.70M | -971.00K | 2.08M | 1.14M | 3.26M | 3.11M | 4.39M | 5.76M | 4.10M | 4.53M | 4.41M | 3.57M | 2.64M | 2.90M | 2.65M | 1.83M | 1.50M | 1.26M | 1.17M | 1.11M | 989.66K | 1.05M | 982.46K | 1.10M | 1.10M | 900.00K | 800.00K | 600.00K | 500.00K | 400.00K | 400.00K | 100.00K | 100.00K | 100.00K | 0.00 |
| Net Income | -254.25M | 930.00K | 1.87M | 3.27M | 1.35M | 7.48M | -2.96M | 11.18M | 11.17M | 9.58M | 9.00M | 8.45M | 7.92M | 6.18M | 4.77M | 4.79M | 4.61M | 3.96M | 2.81M | 2.31M | 2.13M | 2.13M | 2.03M | 1.83M | 2.11M | 2.10M | 2.10M | 1.70M | 1.60M | 1.20M | 1.00M | 900.00K | 900.00K | 900.00K | 400.00K | 100.00K | 0.00 |
| Net Income Ratio | -117.60% | 0.42% | 1.01% | 2.44% | 1.15% | 7.26% | -3.08% | 11.94% | 13.19% | 13.43% | 17.07% | 18.20% | 19.99% | 18.84% | 21.75% | 22.24% | 23.57% | 22.96% | 24.22% | 23.03% | 23.34% | 23.42% | 22.46% | 20.13% | 24.34% | 25.93% | 26.58% | 21.79% | 19.75% | 18.18% | 16.13% | 20.45% | 23.68% | 25.71% | 14.29% | 9.09% | 0.00% |
| EPS | -47.20 | 0.17 | 0.36 | 0.66 | 0.32 | 1.95 | -0.79 | 3.04 | 3.10 | 2.72 | 2.61 | 2.52 | 2.41 | 1.91 | 1.49 | 1.51 | 1.46 | 1.25 | 0.94 | 0.76 | 0.70 | 0.66 | 0.60 | 0.59 | 0.55 | 0.51 | 0.48 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| EPS Diluted | -47.20 | 0.17 | 0.35 | 0.64 | 0.31 | 1.86 | -0.79 | 2.91 | 2.97 | 2.63 | 2.49 | 2.35 | 2.29 | 1.86 | 1.45 | 1.48 | 1.41 | 1.22 | 0.92 | 0.74 | 0.68 | 0.64 | 0.59 | 0.59 | 0.55 | 0.50 | 0.47 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| Weighted Avg Shares Out | 5.39M | 5.32M | 5.21M | 4.98M | 4.20M | 3.84M | 3.75M | 3.68M | 3.61M | 3.52M | 3.45M | 3.36M | 3.29M | 3.23M | 3.19M | 3.18M | 3.17M | 3.16M | 2.99M | 3.06M | 3.05M | 3.23M | 3.41M | 3.69M | 3.82M | 4.14M | 4.30M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
| Weighted Avg Shares Out (Dil) | 5.39M | 5.36M | 5.34M | 5.12M | 4.37M | 4.03M | 3.77M | 3.84M | 3.76M | 3.65M | 3.61M | 3.59M | 3.46M | 3.33M | 3.29M | 3.24M | 3.28M | 3.23M | 3.05M | 3.14M | 3.14M | 3.30M | 3.45M | 3.72M | 3.84M | 4.17M | 4.40M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
LAKEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, announced the completed acquisition of GKE-GmbH's...
Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
LAKEWOOD, Colo., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, February 5, 2024.
Mesa Labs Announces Second Quarter Results
LAKEWOOD, Colo., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q24”) ended September...
Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform
Lakewood, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the completed acquisition of...
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The...
Bear of the Day: Mesa Labs (MLAB)
Mesa Labs ( MLAB ) is a small-cap medical provider of quality control monitoring and validation instruments serving niche markets in healthcare, industrial, pharmaceutical, medical and food processing applications. I have followed this small company for several years and traded...
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023
LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, November 6, 2023.
Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions
LAKEWOOD, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced its commitment to calculate...
Mesa Labs (MLAB) Surpasses Q1 Earnings Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $1.17 per share a year ago.
Mesa Labs Announces First Quarter Results
LAKEWOOD, Colo., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q24”) ended June...
Source: https://incomestatements.info
Category: Stock Reports